Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raum, W. J.
Right arrow Articles by Swerdloff, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raum, W. J.
Right arrow Articles by Swerdloff, R. S.
Agricola
Right arrow Articles by Raum, W. J.
Right arrow Articles by Swerdloff, R. S.

Biology of Reproduction, Vol 30, 388-396, Copyright © 1984 by Society for the Study of Reproduction

ARTICLES

Nuclear accumulation of estradiol derived from the aromatization of testosterone is inhibited by hypothalamic beta-receptor stimulation in the neonatal female rat

WJ Raum, M Marcano and RS Swerdloff

We previously reported that hypothalamic beta-adrenergic receptor stimulation prevents testosterone (T)-induced androgenization (defeminization) of the female neonatal rat hypothalamus. It was hypothesized that hypothalamic beta-receptor stimulation blocks androgenization by reducing the nuclear accumulation of estradiol (E2) derived from the aromatization of T. Various adrenergic agonists and antagonists were injected intracerebrally in 4-day-old female rats. [3H] T and its 3H-metabolites (including E2) were extracted from hypothalamic nuclear pellets, and separated from one another with thin- layer chromatography and/or Celite chromatography. The ratio of recovered [3H] T and E2 in the control groups was arbitrarily assigned as a 100% conversion and nuclear accumulation. Phenoxybenzamine, an alpha-antagonist, and isoproterenol and isoxsuprine, beta-agonists, inhibited the nuclear accumulation of E2 to 66.7%, 69.0% and 85.0% of control, respectively. A nonadrenergic, specific, competitive aromatase inhibitor, 1,4,6-androstratrien-3,17-dione (ATD) inhibited aromatization (and subsequent nuclear accumulation) to 39.0% of control. The beta-antagonist, hydroxybenzylpindolol, specifically prevented the inhibition of nuclear accumulation produced by phenoxybenzamine, isoproterenol and isoxsuprine, but did not alter the inhibition of aromatization produced by ATD. These studies support the hypothesis that beta-receptor stimulation prevents androgenization of the brain by inhibiting either the aromatization of T to E2 or the nuclear uptake of E2.


This article has been cited by other articles:


Home page
 ReproductionHome page
C A Wilson and D C Davies
The control of sexual differentiation of the reproductive system and brain
Reproduction, February 1, 2007; 133(2): 331 - 359.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. A. Cornil, C. Dalla, Z. Papadopoulou-Daifoti, M. Baillien, C. Dejace, G. F. Ball, and J. Balthazart
Rapid Decreases in Preoptic Aromatase Activity and Brain Monoamine Concentrations after Engaging in Male Sexual Behavior
Endocrinology, September 1, 2005; 146(9): 3809 - 3820.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
E. Diamanti-Kandarakis, G. Tolis, and A. J. Duleba
Androgens and Therapeutic Aspects of Antiandrogens in Women
Reproductive Sciences, July 1, 1995; 2(4): 577 - 592.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Society for the Study of Reproduction.